Search Results

Saracatinib (AZD0530) 25mg  | 99.86%

APEXBIO TECHNOLOGY LLC

Src/Abl inhibitor,potent and selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Saracatinib (AZD0530)

Saracatinib (AZD0530) 100mg  | 99.86%

APEXBIO TECHNOLOGY LLC

Src/Abl inhibitor,potent and selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Saracatinib (AZD0530)

Bosutinib (SKI-606) 10mM (in 1mL DMSO)  | 99.37%

APEXBIO TECHNOLOGY LLC

Potent Abl/Src kinases TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Bosutinib (SKI-606)

Bosutinib (SKI-606) 5mg  | 99.37%

APEXBIO TECHNOLOGY LLC

Potent Abl/Src kinases TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Bosutinib (SKI-606)

Bosutinib (SKI-606) 100mg  | 99.37%

APEXBIO TECHNOLOGY LLC

Potent Abl/Src kinases TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Bosutinib (SKI-606)

PRX-08066 Maleic acid 5mg  | 98%

APEXBIO TECHNOLOGY LLC

5-HT2B receptor antagonist,potent and selective Neuroscience|5-HT Receptor

More Information Supplier Page

×

PRX-08066 Maleic acid

PRX-08066 Maleic acid 10mg  | 98%

APEXBIO TECHNOLOGY LLC

5-HT2B receptor antagonist,potent and selective Neuroscience|5-HT Receptor

More Information Supplier Page

×

PRX-08066 Maleic acid

Saracatinib (AZD0530) 10mM (in 1mL DMSO)  | 99.86%

APEXBIO TECHNOLOGY LLC

Src/Abl inhibitor,potent and selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Saracatinib (AZD0530)

Saracatinib (AZD0530) Evaluation Sample  | 99.86%

APEXBIO TECHNOLOGY LLC

Src/Abl inhibitor,potent and selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Saracatinib (AZD0530)

Saracatinib (AZD0530) 5mg  | 99.86%

APEXBIO TECHNOLOGY LLC

Src/Abl inhibitor,potent and selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Saracatinib (AZD0530)